Peter Richardson
33Patents
7h-index
22Co-inventors
69Inventor score
Filing activity: Jan 11, 1984 → Nov 25, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8119593B2 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin | Human Necessities | 102 | Active |
| US8372804B2 | Delivery of active agents | Human Necessities | 58 | Active |
| US8377869B2 | Method of preventing adverse effects by GLP-1 | Human Necessities | 55 | Active |
| US8911496B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 25 | Active |
| US8409277B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 15 | Active |
| US4999250A | Composition and use | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8709029B2 | Apparatus and method for securing ocular tissue | Human Necessities | 7 | Active |
| US6331520A | Pharmaceutical compositions of peptides having low solubility in physiological medium | Human Necessities | 6 | Expired |
| US9504559B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 4 | Active |
| US9717588B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 4 | Active |
| US7927372B2 | Scleral prosthesis having crossbars for treating presbyopia and other eye disorders | Human Necessities | 4 | Active |
| US9486310B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 4 | Active |
| US10285804B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 3 | Active |
| US4550206A | Method of preparing tetrahalobenzene compounds, chemical intermediates used therein and certain of the compounds themselves | Chemistry; Metallurgy | 3 | Expired |
| US9452044B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 2 | Active |
| US9700406B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 2 | Active |
| US9730785B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 2 | Active |
| US9687339B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 2 | Active |
| US9498324B2 | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods | Human Necessities | 2 | Active |
| US7759321B2 | Compounds for the treatment of pain | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7790698B2 | Use of adenosine receptor agonists in therapy | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8252766B2 | Use of spongosine for the treatment of pain | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11304992B2 | Inhalable dry powder pharmaceutical composition | Human Necessities | 0 | Active |
| US11998591B2 | Method of treating diabetes type 2 by administering ultrarapid acting insulin | Human Necessities | 0 | Active |
| US11311552B2 | Therapies for cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.